ResearcherKyushu UniversityNo recent work listed
Yasuhiro Oyama
Matched on OpenAlex author ID A5111872126. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2016: 1 paper · 2017: 1 paper · 2018: none · 2019: none · 2020: 2 papers · 2021: 1 paper · 2022: 1 paper
Papers 6
- PTPN3 Could Βe a Therapeutic Target of Pancreatic Cancer. Co-author DOI 10.21873/anticanres.15768↗
- TrkB/BDNF Signaling Could Be a New Therapeutic Target for Pancreatic Cancer. Co-author DOI 10.21873/anticanres.15205↗
- Patched 1-interacting Peptide Represses Fibrosis in Pancreatic Cancer to Augment the Effectiveness of Immunotherapy. Co-author DOI 10.1097/cji.0000000000000305↗
- FAM115C could be a novel tumor suppressor associated with prolonged survival in pancreatic cancer patients. Co-author DOI 10.7150/jca.38399↗
- Liprin-α4 as a Possible New Therapeutic Target for Pancreatic Cancer. Co-author DOI 10.21873/anticanres.12122↗
- Protein-bound Polysaccharide-K Inhibits Hedgehog Signaling Through Down-regulation of MAML3 and RBPJ Transcription Under Hypoxia, Suppressing the Malignant Phe… Co-author PMID 27466498↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hideya Onishi · 6 shared papers, 2016–2022 · strength 0.59
- Paper PTPN3 Could Βe a Therapeutic Target of Pancreatic Cancer. DOI 10.21873/anticanres.15768↗
- Paper TrkB/BDNF Signaling Could Be a New Therapeutic Target for Pancreatic Cancer. DOI 10.21873/anticanres.15205↗
- Paper Patched 1-interacting Peptide Represses Fibrosis in Pancreatic Cancer to Augment the Effectiveness of Immunotherapy. DOI 10.1097/cji.0000000000000305↗
- Akio Yamasaki · 4 shared papers, 2016–2022 · strength 0.40
- Paper PTPN3 Could Βe a Therapeutic Target of Pancreatic Cancer. DOI 10.21873/anticanres.15768↗
- Paper TrkB/BDNF Signaling Could Be a New Therapeutic Target for Pancreatic Cancer. DOI 10.21873/anticanres.15205↗
- Paper Liprin-α4 as a Possible New Therapeutic Target for Pancreatic Cancer. DOI 10.21873/anticanres.12122↗
- Makoto Kawamoto · 4 shared papers, 2016–2020 · strength 0.33
- Paper Patched 1-interacting Peptide Represses Fibrosis in Pancreatic Cancer to Augment the Effectiveness of Immunotherapy. DOI 10.1097/cji.0000000000000305↗
- Paper FAM115C could be a novel tumor suppressor associated with prolonged survival in pancreatic cancer patients. DOI 10.7150/jca.38399↗
- Paper Liprin-α4 as a Possible New Therapeutic Target for Pancreatic Cancer. DOI 10.21873/anticanres.12122↗
- Akira Imaizumi · 3 shared papers, 2016–2020 · strength 0.23
- Paper Patched 1-interacting Peptide Represses Fibrosis in Pancreatic Cancer to Augment the Effectiveness of Immunotherapy. DOI 10.1097/cji.0000000000000305↗
- Paper Liprin-α4 as a Possible New Therapeutic Target for Pancreatic Cancer. DOI 10.21873/anticanres.12122↗
- Paper Protein-bound Polysaccharide-K Inhibits Hedgehog Signaling Through Down-regulation of MAML3 and RBPJ Transcription Unde… PMID 27466498↗
- Takashi Morisaki · 2 shared papers, 2020–2021 · strength 0.22
- Shinjiro Nagao · 1 shared paper, 2021 · strength 0.12
- Ryota Matsuda · 1 shared paper, 2020 · strength 0.10
- Yoshinao Oda · 1 shared paper, 2020 · strength 0.10
- Kiyoshi Saeki · 1 shared paper, 2020 · strength 0.10
- Masafumi Nakamura · 1 shared paper, 2020 · strength 0.10
- Masafumi Nakamura · 1 shared paper, 2020 · strength 0.10
- Yoshihiro Miyasaka · 1 shared paper, 2020 · strength 0.10
- Kenoki Ohuchida · 1 shared paper, 2020 · strength 0.10
- Mitsuo Katano · 1 shared paper, 2016 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.